Whitefort Capital Management, LP
Whitefort Capital Management, LP reported 19 holdings worth US$406M as of Jun 30, 2026 (Form 13F)
As of Jun 30, 2026 · Filed Aug 14, 2026
Whitefort Capital Management, LP reported 19 holdings worth US$406M as of Jun 30, 2026. Largest: Arbutus Biopharma Corporation, Roivant Sciences Ltd. and Bally's Corporation. Filed Aug 14, 2026 (Form 13F).
- Holdings
- 19
- Value as reported
- US$406M
The filing in full
| Company | Shares | Value as reported | % of portfolio |
|---|---|---|---|
| Arbutus Biopharma Corporation | 15.8M | US$75.8M | 18.7% |
| Roivant Sciences Ltd. | 1.02M | US$36.1M | 8.9% |
| Bally's Corporation | 2.41M | US$33M | 8.1% |
| Genworth Financial Inc | 3.13M | US$29.6M | 7.3% |
| Nextnav Inc. | 1.6M | US$28.5M | 7.0% |
| Omniab, Inc. | 10.2M | US$25.2M | 6.2% |
| Ziff Davis, Inc. | 418K | US$21.9M | 5.4% |
| Usa Today Co., Inc. | 2M | US$17.1M | 4.2% |
| Cadiz, Inc. | 3.99M | US$16.7M | 4.1% |
| Surgery Partners, Inc. | 901K | US$15.1M | 3.7% |
| Pubmatic, Inc. | 1.11M | US$14.6M | 3.6% |
| Innovate Corp. | 743K | US$13.9M | 3.4% |
| Sable Offshore Corp. | 3.72M | US$11.5M | 2.8% |
| Opko Health, Inc. | 4.51M | US$6.77M | 1.7% |
| Teads Holding Co. | 4.61M | US$3.53M | 0.87% |
| Kestrel Group, Ltd. | 161K | US$1.45M | 0.36% |